A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
- PMID: 31510088
- PMCID: PMC6780967
- DOI: 10.3390/medsci7090095
A Review of First Line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome
Abstract
Polycystic ovary syndrome (PCOS) is the most common cause of anovulatory infertility in women of reproductive age. Lifestyle change is considered the first line treatment for the management of infertile anovulatory women with PCOS, and weight loss for those who are overweight or obese. First line medical ovulation induction therapy to improve fertility outcomes is letrozole, whilst other less efficacious ovulation induction agents, such as clomiphene citrate, metformin, and metformin combined with clomiphene citrate, may also be considered. Metformin combined with clomiphene citrate is more effective than clomiphene citrate alone. In obese women with PCOS, clomiphene citrate could be used in preference to metformin alone whilst clomiphene citrate could be added to metformin alone in order to improve reproductive outcome in all women with PCOS. Gonadotrophins, which are more effective than clomiphene citrate in therapy naïve women with PCOS, can be considered a first line therapy in the presence of ultrasound monitoring, following counselling on the cost and the potential risk of multiple pregnancy.
Keywords: infertility; ovulation induction; polycystic ovary syndrome; treatment.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.Hum Reprod Update. 2019 Nov 5;25(6):717-732. doi: 10.1093/humupd/dmz029. Hum Reprod Update. 2019. PMID: 31647106
-
The treatment of infertility in polycystic ovary syndrome: a brief update.Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):400-3. doi: 10.1111/j.1479-828X.2012.01448.x. Epub 2012 May 28. Aust N Z J Obstet Gynaecol. 2012. PMID: 22639834 Review.
-
Ovulation induction in polycystic ovary syndrome.J Obstet Gynaecol Can. 2010 May;32(5):495-502. doi: 10.1016/S1701-2163(16)34504-2. J Obstet Gynaecol Can. 2010. PMID: 20500959
-
A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome.Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):867-873. doi: 10.1111/ajo.13051. Epub 2019 Sep 12. Aust N Z J Obstet Gynaecol. 2019. PMID: 31514246 Review.
-
A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome.Med Sci (Basel). 2019 Jun 26;7(7):75. doi: 10.3390/medsci7070075. Med Sci (Basel). 2019. PMID: 31247909 Free PMC article. Review.
Cited by
-
Primer on Female Infertility for the Reproductive Urologist.Urol Res Pract. 2023 Nov;49(6):338-344. doi: 10.5152/tud.2023.23167. Urol Res Pract. 2023. PMID: 37971387 Free PMC article.
-
A novel link between KCNQ1 genetic variants and polycystic ovary syndrome susceptibility.Biomed Rep. 2025 Apr 22;22(6):104. doi: 10.3892/br.2025.1982. eCollection 2025 Jun. Biomed Rep. 2025. PMID: 40322554 Free PMC article.
-
The Effects of Separate and Combined Treatment of Male Rats with Type 2 Diabetes with Metformin and Orthosteric and Allosteric Agonists of Luteinizing Hormone Receptor on Steroidogenesis and Spermatogenesis.Int J Mol Sci. 2021 Dec 24;23(1):198. doi: 10.3390/ijms23010198. Int J Mol Sci. 2021. PMID: 35008624 Free PMC article.
-
Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2022 May 17;2022:4395612. doi: 10.1155/2022/4395612. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35620410 Free PMC article.
-
Long-term outcomes of switching to gonadotrophins versus continuing with clomiphene citrate, with or without intrauterine insemination, in women with normogonadotropic anovulation and clomiphene failure: follow-up study of a factorial randomized clinical trial.Hum Reprod. 2023 Mar 1;38(3):421-429. doi: 10.1093/humrep/deac268. Hum Reprod. 2023. PMID: 36622200 Free PMC article. Clinical Trial.
References
-
- Walls M.L., Hunter T., Ryan J.P., Keelan J.A., Nathan E., Hart R.J. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: A comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum. Reprod. 2015;30:88–96. doi: 10.1093/humrep/deu248. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical